Marloes Verstappen
- Rheumatology top 5%
- Rheumatoid Arthritis Research and Therapies 18
- Systemic Lupus Erythematosus Research 12
- Musculoskeletal synovial abnormalities and treatments 3
- Spondyloarthritis Studies and Treatments 1
- Hematology top 10%
- Autoimmune and Inflammatory Disorders Research 6
-
- Chronic Lymphocytic Leukemia Research 2
-
- Monoclonal and Polyclonal Antibodies Research 5
-
- Viral Infections and Immunology Research 3
- Co-authors
- Annette H M van der Helm–van MilPascal H P de JongX. MatthijssenElise van MulligenEllis NiemantsverdrietFenne WoutersT. HuizingaAleid C. Boer
- Cited by
- RheumatologyHematologyGenetics
- Partner nations
- NetherlandsUnited StatesRussia
In The Last Decade
Marloes Verstappen
19 papers receiving 313 citations
Hit Papers
Peers
Comparison fields: 5 of 45
- Rheumatology 271
- Hematology 80
- Genetics 39
- Radiology, Nuclear Medicine and Imaging 55
- Immunology 47
Countries citing papers authored by Marloes Verstappen
This map shows the geographic impact of Marloes Verstappen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marloes Verstappen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marloes Verstappen more than expected).
Fields of papers citing papers by Marloes Verstappen
This network shows the impact of papers produced by Marloes Verstappen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marloes Verstappen. The network helps show where Marloes Verstappen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marloes Verstappen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 2 | |
| 5 | 2022 | 8 | |
| 6 | 2022 | 11 | |
| 7 | 2022 | 12 | |
| 8 | 2022 | 11 | |
| 9 | Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trialbreakdown → | 2022 | 96 |
| 10 | 2022 | 8 | |
| 11 | 2022 | 8 | |
| 12 | 2022 | 18 | |
| 13 | 2021 | 63 | |
| 14 | 2021 | 2 | |
| 15 | 2021 | 2 | |
| 16 | 2021 | 4 | |
| 17 | 2021 | 13 | |
| 18 | 2020 | 35 | |
| 19 | 2020 | 15 |
About Marloes Verstappen
Marloes Verstappen is a scholar working on Rheumatology, Hematology and Radiology, Nuclear Medicine and Imaging, having authored 19 papers that have together received 315 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (18 papers), Systemic Lupus Erythematosus Research (12 papers), Autoimmune and Inflammatory Disorders Research (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Musculoskeletal synovial abnormalities and treatments (3 papers), Viral Infections and Immunology Research (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Spondyloarthritis Studies and Treatments (1 paper). The work is most often cited by research in Rheumatology (271 citations), Hematology (80 citations) and Genetics (39 citations). Marloes Verstappen has collaborated with scholars based in Netherlands, United States and Russia. Frequent co-authors include Annette H M van der Helm–van Mil, Pascal H P de Jong, X. Matthijssen, Elise van Mulligen, Ellis Niemantsverdriet, Fenne Wouters, T. Huizinga, Aleid C. Boer, Esmeralda T. H. Molenaar and Dirkjan van Schaardenburg. Their work appears in journals such as The Lancet, Annals of the Rheumatic Diseases and Lara D. Veeken.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.